WYKINDA T FANTROY
Allopathic & Osteopathic Physicians|Family Medicine TAMPA, FL NPI 1295585016
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine FL Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$568.57
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $568.57 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $568.57 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $260.80 | 2 |
| UCB, Inc. | $121.12 | 1 |
| Sumitomo Pharma America, Inc. | $116.70 | 1 |
| Acerta Pharma LLC | $41.21 | 2 |
| ARGENX US, INC. | $28.74 | 2 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $568.57 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1110531737 | AstraZeneca Pharmaceuticals LP | $14.94 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110536972 | AstraZeneca Pharmaceuticals LP | $26.27 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142147062 | ARGENX US, INC. | $14.37 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142149192 | ARGENX US, INC. | $14.37 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143166416 | UCB, Inc. | $121.12 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148958852 | Sumitomo Pharma America, Inc. | $116.70 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150919364 | Neurocrine Biosciences, Inc. | $133.31 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150920046 | Neurocrine Biosciences, Inc. | $127.49 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.